PMC:7212965 / 1786-2236 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":2,"end":9},"obj":"Body_part"},{"id":"T7","span":{"begin":173,"end":178},"obj":"Body_part"},{"id":"T8","span":{"begin":359,"end":364},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma82749"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T6","span":{"begin":173,"end":178},"obj":"Body_part"},{"id":"T7","span":{"begin":359,"end":364},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":142,"end":150},"obj":"Disease"},{"id":"T10","span":{"begin":236,"end":244},"obj":"Disease"},{"id":"T11","span":{"begin":427,"end":435},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":173,"end":178},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T18","span":{"begin":173,"end":178},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T19","span":{"begin":359,"end":364},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T20","span":{"begin":359,"end":364},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":2,"end":9},"obj":"Chemical"},{"id":"T8","span":{"begin":295,"end":297},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_16449"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T11","span":{"begin":142,"end":150},"obj":"Phenotype"},{"id":"T12","span":{"begin":152,"end":167},"obj":"Phenotype"},{"id":"T13","span":{"begin":173,"end":192},"obj":"Phenotype"},{"id":"T14","span":{"begin":236,"end":244},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002017"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0001392"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":52,"end":285},"obj":"Sentence"},{"id":"T16","span":{"begin":286,"end":328},"obj":"Sentence"},{"id":"T17","span":{"begin":329,"end":436},"obj":"Sentence"},{"id":"T18","span":{"begin":438,"end":449},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}

{"project":"LitCovid-PubTator","denotations":[{"id":"53","span":{"begin":295,"end":297},"obj":"Gene"},{"id":"62","span":{"begin":142,"end":150},"obj":"Disease"},{"id":"63","span":{"begin":152,"end":158},"obj":"Disease"},{"id":"64","span":{"begin":159,"end":167},"obj":"Disease"},{"id":"65","span":{"begin":173,"end":192},"obj":"Disease"},{"id":"66","span":{"begin":236,"end":244},"obj":"Disease"},{"id":"67","span":{"begin":427,"end":435},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Gene:2770"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D003967"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D009325"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D014839"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D008107"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D003967"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more prevalent outside of China, with diarrhea reported in 18.3% (95% CI, 16.6%–20.1%). Isolated GI symptoms were reported rarely. We also summarized the Gl and liver adverse effects of the most commonly utilized medications for COVID-19.\n\nConclusions\n"}